User menu

Variation in the Use of Ondansetron As An Antiemetic Drug in Children Treated With Chemotherapy

Bibliographic reference Ninane, J. ; Ozkaynak, MF. ; Kurtin, P. ; Siegel, SE.. Variation in the Use of Ondansetron As An Antiemetic Drug in Children Treated With Chemotherapy. In: Medical and Pediatric Oncology, Vol. 25, no. 1, p. 33-37 (1995)
Permanent URL http://hdl.handle.net/2078.1/48070
  1. Terrin, J Pediatr, 104, 138 (1984)
  2. Jones, Br J Hosp Med, 45, 85 (1991)
  3. Richardson, Nature, 3165, 126 (1985)
  4. Kilpatrick, Nature, 330, 746 (1987)
  5. Andrews, Br J Pharmacol, 91, 417 (1987)
  6. Smith, Eur J Cancer Clin Oncol, 25, s47 (1989)
  7. De Mulder Pieter H. M., Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting : A Multicenter, Randomized, Double-Blind, Crossover Study, 10.7326/0003-4819-113-11-834
  8. Carden, J Clin Oncol, 8, 1531 (1990)
  9. Pinkerton, Arch Dis Child, 65, 822 (1990)
  10. Sullivan, N Zeal Med J, 105, 369 (1992)
  11. Hewitt, Bone Marrow Transplant, 7, 431 (1991)
  12. Jurgens, Oncology, 49, 279 (1992)
  13. Coates, Eur J Cancer Clin Oncol, 19, 203 (1983)
  14. Butler A., Hill J.M., Ireland S.J., Jordan C.C., Tyers M.B., Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors, 10.1111/j.1476-5381.1988.tb11542.x
  15. Gralla, Eur J Cancer, 27, s1 (1991)